Antimicrobial potential of Protoporhyrin IX-antimicrobial peptide conjugates against Pseudomonas aeruginosa

The combination of photosensitizers and antimicrobial peptides (AMPs) enhances the efficacy of antimicrobial photodynamic inactivation (aPDI). In this study, we evaluated the activity of Protoporphyrin IX and two AMPs—CAMEL and Pexiganan—including their conjugates. The reference strain Pseudomonas aeruginosa ATCC 10145 was used. Photoinactivation experiments were conducted for the photosensitizer (PS) alone, the mixture of PS and AMPs, and their conjugates. PS accumulation was assessed, and the potential for resistance development was evaluated. The findings confirm that AMPs can enhance PS uptake into bacterial cells. Moreover, the Protoporphyrin IX–Pexiganan conjugate was the most effective in aPDI. Further evaluation demonstrated that this compound does not induce resistance development. This study highlights the effectiveness of this approach. The synergy between Pexiganan and Protoporphyrin IX against P. aeruginosa was confirmed. Further research is needed to assess the efficacy of the tested compound against other bacterial strains.

Authors

Institutions

Publication Details

Journal
Photodiagnosis and Photodynamic Therapy
Published
2025-11-01
DOI
https://doi.org/10.1016/j.pdpdt.2025.105078
Primary Topic
Photodynamic Therapy Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Antimicrobial potential of Protoporhyrin IX-antimicrobial peptide conjugates against Pseudomonas aeruginosa

Damian Neubauer, Joanna Nakonieczna, Wojciech Kamysz, Yanina Dashkievich
Photodiagnosis and Photodynamic Therapy
Photodynamic Therapy Research Studies
article

Antimicrobial potential of Protoporhyrin IX-antimicrobial peptide conjugates against Pseudomonas aeruginosa

Damian Neubauer, Joanna Nakonieczna, Wojciech Kamysz, Yanina Dashkievich
article en

Abstract

The combination of photosensitizers and antimicrobial peptides (AMPs) enhances the efficacy of antimicrobial photodynamic inactivation (aPDI). In this study, we evaluated the activity of Protoporphyrin IX and two AMPs—CAMEL and Pexiganan—including their conjugates. The reference strain Pseudomonas aeruginosa ATCC 10145 was used. Photoinactivation experiments were conducted for the photosensitizer (PS) alone, the mixture of PS and AMPs, and their conjugates. PS accumulation was assessed, and the potential for resistance development was evaluated. The findings confirm that AMPs can enhance PS uptake into bacterial cells. Moreover, the Protoporphyrin IX–Pexiganan conjugate was the most effective in aPDI. Further evaluation demonstrated that this compound does not induce resistance development. This study highlights the effectiveness of this approach. The synergy between Pexiganan and Protoporphyrin IX against P. aeruginosa was confirmed. Further research is needed to assess the efficacy of the tested compound against other bacterial strains.

Photodiagnosis and Photodynamic TherapyVol. 56
University of Gdańsk (PL), Gdańsk Medical University (PL)
Openalex Percentile: Top 50%
Photodynamic Therapy Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.